Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance.

For more Information, see https://techcrunch.com/2018/02/21/cognoas-ai-platform-for-autism-diagnosis-gets-first-fda-stamp/